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We developed a screening method for orphan
receptor ligands, in which cell-surface proteins are
expressed inDrosophila embryos fromGAL4-depen-
dent insertion lines and ligand candidates identified
by the presence of ectopic staining with receptor
fusion proteins. Stranded at second (Sas) binds
to the receptor tyrosine phosphatase Ptp10D in
embryos and in vitro. Sas and Ptp10D can interact
in trans when expressed in cultured cells. Interac-
tions between Sas and Ptp10D on longitudinal axons
are required to prevent them from abnormally
crossing the midline. Sas is expressed on both
neurons and glia, whereas Ptp10D is restricted to
CNS axons. We conducted epistasis experiments
by overexpressing Sas in glia and examining how
the resulting phenotypes are changed by removal
of Ptp10D from neurons. We find that neuronal
Ptp10D restrains signaling by overexpressed glial
Sas, which would otherwise produce strong glial
and axonal phenotypes.
INTRODUCTION
Receptor tyrosine phosphatases (RPTPs) are single-span trans-
membrane proteins that reverse reactions catalyzed by tyrosine
kinases (TKs). A major problem in the phosphotyrosine signaling
field is to identify and characterize ligands and coreceptors that
interact with the extracellular (XC) domains of RPTPs and regu-
late their functions in vivo.
The IIb, IIa, and III subtypes, comprising 11 of the 19 human
RPTPs, have XC regions containing immunoglobulin-like (Ig)
domains and fibronectin type III (FN3) repeats, which are found
in cell adhesion molecules (CAMs) (reviewed by Tonks, 2006).
Type IIb RPTPs are homophilic CAMs that regulate cadherin-
mediated adhesion (Aricescu et al., 2007). Type IIa (Lar-like)
RPTPs bind to heparan sulfate (HSPG) and chondroitin sulfate
(CSPG) proteoglycans (Aricescu et al., 2002; Coles et al., 2011;
Fox and Zinn, 2005; Johnson et al., 2006). The HSPGs Syndecan
(Sdc) and Dallylike (Dlp) are in vivo ligands and coreceptors forDrosophila Lar (Fox and Zinn, 2005; Johnson et al., 2006).
The type III RPTP PTPRB interacts with VE-cadherin in cis
(Nawroth et al., 2002), and PTPRJ can bind to a fragment of
the Syndecan-2 protein (Whiteford et al., 2011).
Dimeric placental alkaline phosphatase (AP) fusion proteins
have been used to visualize ligand binding in situ for many recep-
tors (Flanagan and Cheng, 2000). RPTP-AP probes derived from
the XC domains of four Drosophila RPTPs (Ptp10D, Ptp69D,
Ptp99A, and Lar), all stain CNS axons in live-dissected late stage
16 embryos. Lar-AP also stains muscle attachment sites. This
provided the basis for a screen of deletion (Df) mutations inwhich
we screened the Bloomington Stock Center Df ‘‘kit,’’ found a Df
for which homozygotes lacked muscle attachment site staining
with Lar-AP, and identified Sdc as the Lar ligand/coreceptor
encoded within the deleted region (Fox and Zinn, 2005).
This Df screen had two problems. First, homozygotes for many
Dfs in the kit had severe CNS defects that preclude screening. To
alleviate this, we replaced Dfs for which development failed with
smaller Dfs that allow better development, creating a ‘‘pheno-
type Df kit’’ with which >80% of the genome can be screened
for ligands (http://fly.bio.indiana.edu/Browse/df/zinn.php). This
kit can also be used for systematic genome screening for any
embryonic phenotype, and such a screen requires analysis of
less than 400 lines (Wright et al., 2010).
Second, if multiple RPTP ligands are expressed in overlap-
ping patterns, deletion of a gene encoding one ligand might
not produce a decrease in staining that can be unambiguously
scored. For Lar-AP, deletion of Sdc only slightly reduces axonal
staining. A Lar-AP mutant that cannot bind to HSPGs stained
CNS axons with equal intensity in wild-type and Sdc embryos,
indicating that Lar has non-HSPG axonal binding partners
(Fox and Zinn, 2005).
In this paper, we describe a screen that addresses the sec-
ond problem. GAL4-dependent expression of Sdc on muscles
conferred bright staining with Lar-AP (Fox and Zinn, 2005).
This suggested that if we ectopically expressed many cell-sur-
face and secreted (CSS) proteins, potential ligands could be
identified by ectopic staining with RPTP-AP probes. We had
assembled a collection of lines bearing P element insertions
with GAL4 binding sites upstream of 410 CSS protein genes in
order to screen for genes involved in targeting of motor axons
to muscle fibers (Kurusu et al., 2008). These lines were later
used to find genes affecting axonal and dendritic targeting in
the antennal lobe (Hong et al., 2009, 2012).Neuron 78, 813–826, June 5, 2013 ª2013 Elsevier Inc. 813
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Interactions of Ptp10D with a Cell Surface LigandScreening the CSS insertion lines for ectopic staining with
Ptp10D-AP (10D-AP) identified a binding partner for Ptp10D,
Stranded at second (Sas). The sas gene encodes two large
cell-surface proteins of unknown function that are expressed
on the apical surfaces of epithelially derived cells (Schonbaum
et al., 1992).
Ptp10D is a type III RPTP. It is orthologous to a group of four
mammalian RPTPs that negatively regulate receptor TKs
(RTKs) by direct dephosphorylation (reviewed by Matozaki
et al., 2010). PTPRJ (DEP-1/CD148), which corresponds to the
Suppressor of colon cancer 1 (Scc1) gene (Ruivenkamp et al.,
2002) dephosphorylates the epidermal growth factor receptor
(EGFR), vascular endothelial growth factor receptor (VEGFR),
and CSF1R/Met growth factor RTKs (Chabot et al., 2009; Palka
et al., 2003; Tarcic et al., 2009). PTPRB (VE-PTP) regulates Tie-2
(Winderlich et al., 2009), and PTPRO regulates TrkC and Eph
RTKs (Hower et al., 2009; Shintani et al., 2006). Type III RPTPs
can be tyrosine-phosphorylated on a C-terminal YxNF (F =
hydrophobic) motif, and this causes activation of Src-family tyro-
sine kinases (SFKs) (Murata et al., 2010).
Ptp10D is expressed on CNS axons (Tian et al., 1991; Yang
et al., 1991) and in the tracheal system (Jeon and Zinn, 2009).
In the tracheae, it negatively regulates several growth factor
RTK orthologs, and it associates with EGFR in cultured cells
(Jeon et al., 2012; Jeon and Zinn, 2009). It also has theC-terminal
YxNF motif.
Ptp10D single mutants have no known embryonic pheno-
types, but Ptp10D genetically interacts with other Rptp genes.
The analysis of Ptp10D Ptp69D double mutants demonstrated
that Ptp10D is involved in the control of axon guidance across
the midline of the CNS (Sun et al., 2000, 2001). Double mutants
lacking both Ptp10D and the other type III RPTP, Ptp4E, have
unique defects in tracheal tube formation in which unicellular
tubes are converted into spherical cysts (Jeon and Zinn, 2009).
In this paper, we show that Ptp10D binds to Sas in embryos
and in vitro. Loss-of-function (LOF) genetic interaction studies
show that Sas and Ptp10D act together in neurons to control lon-
gitudinal axon guidance. Signaling by Sas in glia is negatively
regulated by its interactions with Ptp10D on neurons.
RESULTS
Identification of Sas as a Ptp10D Binding Partner Using
an Ectopic Expression Screen
To find potential ligands and coreceptors for Ptp10D, we used
10D-AP to stain embryos that ectopically expressed CSS pro-
teins. The set of lines for CSS protein expression was originally
assembled by creating a database of 976 CSS proteins that
includes more than 80 types of XC domains, then collecting lines
bearing insertions of UAS-containing (EP-like) elements in the 50
ends of 410 of the genes (Kurusu et al., 2008).
A total of 311 of these lines, representing all genes encoding
plausible ligand candidates (Table S1 available online), were
crossed to a line bearing two GAL4 drivers, Elav-GAL4 (pan-
neuronal) and 24B-GAL4 (pan-muscle). Live-dissected stage
16 embryos resulting from these crosses were incubated with
10D-AP, followed by fixation and antibody staining (Fox and
Zinn, 2005; Lee et al., 2009) (Figure 1A).814 Neuron 78, 813–826, June 5, 2013 ª2013 Elsevier Inc.In wild-type stage 16 embryos, 10D-AP brightly stains axons in
the ventral nerve cord (VNC) and brain (Figure 1C), but body wall
staining is weak and has no clear pattern (Figures 1D and 1E).We
searched for insertion lines that produced embryos displaying
strong staining of muscle fibers and/or increased staining of
cell bodies and axons in the VNC. One line, GE24911, reproduc-
ibly conferred strong ectopic staining of muscle fibers and
increased VNC staining intensity. This line has an insertion of
an EP-like GE element 226 bp 50 to the transcription start site
of sas (Schonbaum et al., 1992).
Analysis of ectopic Sas expression showed that 24B-GAL4 is
weaker in the double driver line than as a single driver, suggest-
ing that we might have missed some genes due to insufficient
ectopic expression. Accordingly, we repeated the entire screen
using a strong pancellular driver, tubulin (tub)-GAL4, and identi-
fied nine other candidate binding partners (Figure S1). We do not
yet know if these are genuine Ptp10D ligands or coreceptors, as
their binding to Ptp10D has not been examined by ‘‘reverse’’
staining of embryos (see below) or by in vitro binding. Interest-
ingly, one is Ptp10D itself, indicating that the Ptp10D XC domain
may have homophilic binding activity. This was also observed in
a cell aggregation assay (see below).
sas encodes two cell-surface proteins of 1,693 and 1,348
amino acids (aa). The mRNA for the larger isoform includes an
alternatively spliced exon encoding a 345 aa sequence that is
inserted at aa 929. Sas proteins have two XC domains with
defined structures: a von Willebrand factor type C (VWC)
domain (aa 750–825) and two FN3 repeats (aa 1,400–
1,600). There is a single predicted transmembrane domain,
and a short cytoplasmic domain of 37 aa (Schonbaum et al.,
1992). Western blotting of Sas from embryos reveals multiple
bands between 100 kD and 220 kD, suggesting that there are
extracellular Sas proteins that lack transmembrane and cyto-
plasmic sequences. Sas does not have an obvious vertebrate
ortholog, but there are numerous vertebrate proteins with
VWC domains and FN3 repeats homologous to those in Sas.
To confirm that Sas was responsible for ectopic binding of
10D-AP to embryos from GE24911 crosses, we made trans-
genic lines containing a UAS-linked cDNA construct encoding
the large Sas isoform. When these were crossed to a variety
of GAL4 driver lines, we observed ectopic 10D-AP staining in
patterns that corresponded to the expression patterns of the
drivers. Ventrolateral and ventral muscles were brightly labeled
by 10D-AP in embryos expressing Sas from the 24B-GAL4
driver (Figures 1F and 1G). Embryos expressing Sas in glia
from Repo-GAL4 showed increased 10D-AP staining along
peripheral nerves (Figures 1H and 1I). Embryos expressing
Sas from 5053A-GAL4, which is selectively expressed in muscle
12, displayed ectopic 10D-AP staining only on that muscle (Fig-
ures 1J and 1K). We compared 10D-AP and anti-Sas staining in
ectopic expression embryos, and found that the two patterns
were superimposable (Figure S2).
Although ectopic 10D-AP staining is observed wherever Sas is
overexpressed, Sas is not required for axonal staining by
10D-AP. In embryos homozygous for a sas point mutation or a
Df that removes sas, a normal axonal pattern of 10D-AP staining
was observed (data not shown). This indicates that Ptp10D has
other binding partners (see Figure S1).
Figure 1. Identification of Sas in an Ectopic Expression Screen for Binding to 10D-AP
(A) Flowchart of the screen.
All images show live-dissected late stage 16 embryos stained with 10D-AP. The top row of images shows double-labeling of CNS longitudinal tracts and motor
axons with mAb 1D4 (Alexa 488, green) and 10D-AP (Alexa 568, magenta); the bottom row shows 10D-AP labeling alone, in white. The detail images each show
two hemisegments, including the CNS and the ventral and lateral body walls. Anterior is to the left, and dorsal is up.
(B and C) A whole filleted embryo. Note that 10D-AP prominently stains VNC axons (arrowhead) and the brain (white spot; arrow). Scale bar represents 20 mm.
(D and E) Wild-type (yw). The axon tracts of the CNS (out of focus) are stained by 10D-AP, but there is no clear pattern in the body wall. (D) Scale bar represents
20 mm.
(F and G) 24B > Sas. The ventral, ventrolateral, and lateral muscle fibers are brightly stained. Arrowhead indicates muscle 12.
(H and I) Repo > Sas. Peripheral glia surrounding themotor and sensory axon tracts are stained (arrowhead). The CNS is brighter due to staining of CNS glia (out of
focus; arrow).
(J and K) 5053A > Sas. This driver expresses only in muscle 12, which is brightly labeled (arrowhead).
See also Figures S1, S2, and Table S1.
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The fact that ectopic Sas expression confers ectopic staining
with an exogenous Ptp10D fusion protein does not prove that
Sas itself binds to Ptp10D. To determine whether exogenous
Sas can interact with endogenous Ptp10D, we performed
reverse staining experiments, incubating embryos with purified
Sas-Fc, a dimeric human Fc fusion protein containing the XC
domain of the large Sas isoform. In live-dissected wild-type
embryos, we observed only weak staining with Sas-Fc, and we
could not see changes in the staining pattern when we ectopi-
cally expressed Ptp10D using the Ptp10DEP1172 insertion line.
We then made the surprising observation that genetic removal
of the other Drosophila type III RPTP, Ptp4E, which is widely
expressed in embryos (Jeon et al., 2008; Oon et al., 1993),
allowed visualization of ectopic Ptp10D by staining with Sas-Fc.
The simplest explanation for this effect is that heterodimerization
of Ptp4E with Ptp10D blocks Sas binding, but we have no evi-
dence that such heterodimers exist.
Figures 2A–2H show double staining of the VNC with Sas-Fc
and an anti-Ptp10D monoclonal antibody (mAb). In wild-type
embryos, faint staining of CNS axons with Sas-Fc was observed
(Figure 2B). This was increased in intensity in a Ptp4E mutant
(Figure 2D). In aPtp4E Ptp10D doublemutant, no Ptp10D proteinis present (Figure 2E), and the intensity of staining with Sas-Fc
was reduced relative to the Ptp4E single mutant (Figure 2F),
suggesting that Ptp10D is one of the major binding partners for
Sas-Fc on CNS axons. When Ptp10D was overexpressed on
all neurons in a Ptp4E mutant background using the Elav-GAL4
driver, Ptp10D and Sas-Fc staining intensities were increased
(Figures 2G and 2H).
Sas-Fc stained body walls weakly in Ptp4E mutant embryos
(Figure 2J). However, when Ptp10D was pancellularly expressed
in the Ptp4E mutant background using tub-GAL4, bright Sas-Fc
staining (and anti-Ptp10D staining) was observed on muscle
fibers, and VNC staining intensity was increased (Figures 2K
and 2L). These data show that Sas and Ptp10D can interact
with each other in embryos, but do not demonstrate that they
can bind to each other in the absence of other cofactors. To eval-
uate this issue, we analyzed interactions between Sas and
Ptp10D in vitro.
Sas and Ptp10D Bind to Each Other In Vitro
We examined binding in vitro between Sas and Ptp10D using a
modified ELISA assay and the AlphaScreen (Perkin-Elmer),
which measures interactions between proteins bound to beads.
For studies of interactions between cell surface proteins, theseNeuron 78, 813–826, June 5, 2013 ª2013 Elsevier Inc. 815
Figure 2. Sas-Fc Binds to Ptp10D in Embryos
Live-dissected late stage 16 embryos double-stained with anti-Ptp10D mAb (top row) and Sas-Fc (bottom row) using immunofluorescence for detection (Alexa
488 for Ptp10D, Alexa 568 for Sas-Fc).
(A and B) Wild-type. Sas-Fc weakly stains CNS axons. For all CNS images, four segments are shown in each panel; anterior is up. Scale bar represents 10 mm.
(C and D) Ptp4E1. Sas-Fc staining intensity is increased relative to (B). CNS axons are labeled, in addition to staining at the midline (arrow) and on cell bodies,
which are located on the sides of the axon ladder.
(E and F) Ptp4E1 Ptp10D1. No Ptp10D staining is observed in (E). Sas-Fc staining intensity is reduced relative to (D).
(G and H) Ptp4E1, Elav > Ptp10D. The intensity of Ptp10D axonal staining is increased relative to (C), and some cell body staining is observed. Sas-Fc staining
intensity is increased relative to (D), and both axons and cell bodies are stained.
(I and J) Ptp4E1. Two segments of the CNS, ventral, and ventrolateral muscles are shown in each of these four panels; anterior is to the left and dorsal is up.
Anti-Ptp10D stains ganglionic tracheal branches (arrow). Sas-Fc labeling has no clear pattern in the periphery.
(K and L) Ptp4E1, Tub > Ptp10D. The edges of the ventral and ventrolateral muscles are brightly labeled by anti-Ptp10D in (K) and by Sas-Fc in (L). Arrowhead
indicates muscle 6. One brightly labeled, out-of-focus CNS longitudinal tract (bracket) is seen in each panel. This tract is much brighter in (K) versus (I), and in (L)
versus (J), reflecting Ptp10D overexpression and increased Sas-Fc staining on axons.
See also Figure S2 and Table S1.
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down, cell aggregation, and cell adhesion-to-substrate. Two-
hybrid and GST pulldown assays produce unreliable results
with XC domains because they lack normal disulfide bond for-
mation and glycosylation when expressed within yeast or bacte-
rial cells, and cell aggregation and cell adhesion-to-substrate
assays cannot demonstrate that proteins interact in the absence
of cellular cofactors.
The modified ELISA assay was developed for analysis
of Dscam interactions (Wojtowicz et al., 2007). Although we
obtained robust signals with Dscam positive controls, our initial
attempts to measure binding of Sas to Ptp10D produced weak
signals. We made some modifications to the assay that
increased its signal-to-noise ratio by10-fold (see Experimental
Procedures), and were then able to readily demonstrate selec-
tive Sas-Ptp10D interactions.
Figure 3A shows the results of an experiment in which purified
Sas-Fc was used alone (blank) or mixed at an 1:1 molar ratio
with three different RPTP XC domain fusion proteins: 10D-AP,
Ptp69D-AP (69D-AP), or Lar-AP. All proteins were made using
the baculovirus system. Eight identical replicates of each bind-
ing reaction were assessed. Binding was observed only for the
Sas::Ptp10D pair. The mean signal value for Sas::Ptp10D816 Neuron 78, 813–826, June 5, 2013 ª2013 Elsevier Inc.was 30- to 43-fold higher than for any of the three controls,
and these differences were highly statistically significant
(p < 0.0001).
These data show that Sas binds to Ptp10D and not to other
RPTP-AP fusion proteins, but do not address the possibility
that 10D-AP is ‘‘sticky’’ and can bind nonselectively to any Fc
fusion protein. To evaluate this, we conducted the experiment
in Figure 3B, in which 10D-AP was mixed at an 1:1 molar ratio
with two other Fc fusion proteins, Unc5-Fc and Fasciclin II
(FasII)-Fc, with one of the controls from the Figure 3A experi-
ment, Sas-Fc::Lar-AP, serving as the blank. Eight identical repli-
cates of each binding reaction were assessed. As in Figure 3A,
binding was observed only between Ptp10D and Sas. The
mean signal value for Sas::Ptp10D was 13- to 32-fold higher
than for the two Fc controls, and the differences were highly
statistically significant (p < 0.0001 for both the Unc5::10D and
FasII::10D controls).
The AlphaScreen relies on a proximity-dependent chemical
reaction to measure binding between two proteins bound to
‘‘donor’’ and ‘‘acceptor’’ beads. This assay can work well for
low-affinity interactions, because the high concentrations of pro-
tein on the beads facilitate bead-bead interactions via avidity
effects. Cell-cell interactions mediated by adhesion molecules
Figure 3. Sas-Ptp10D Interactions In Vitro and in Cultured Cells
The bar graphs show the absorbance at 370 nm obtained using themodified ELISA assay for the indicated pairs of proteins. The height of each bar represents the
mean of eight replicate assays.
(A) Sas-Fc binds to 10D-AP, but not to 69D-AP or Lar-AP. Actual values for the four pairs are: Sas-Fc::10D-AP: 0.340 ± 0.040 (SD); Sas-Fc::Lar-AP: 0.007 ± 0.001;
Sas-Fc::69D-AP: 0.010 ± 0.002; Sas-Fc::blank: 0.017 ± 0.004. The limit of quantification (LOQ) is given by: LOQ = (mean blank signal) + (103 SD for the blank). If a
signal is above the LOQ it is very unlikely that the difference between the signal and the blank arose by chance. Here LOQ is 0.053, signal is 0.340, and signal/LOQ
is >6.
(B) 10D-AP binds to Sas-Fc, but not to Unc5-Fc or FasII-Fc. Actual values are: Sas-Fc::10D-AP: 0.375 ± 0.104; Sas-Fc::Lar-AP: 0.010 ± 0.004; Unc5-Fc::10D-AP:
0.012±0.002; FasII-Fc::10D-AP: 0.028±0.008. LOQ forUnc5-Fc::10D-AP is 0.031, andsignal/LOQ is12; LOQfor FasII-Fc::10D-AP is 0.111, andsignal/LOQ is3.4.
(C) A field of Ptp10D-expressing stably transfected S2 cells (magenta). A typical cluster is circled (dotted outline). Scale bar represents 20 mm.
(D) A field of Sas-expressing stably transfected S2 cells (green). No clusters form when these cells are incubated alone.
(E) A field of a mixture of Ptp10D and Sas-expressing cells. The outlined cluster of Ptp10D-expressing cells has several green Sas cells associated with it.
See also Figure S3 and Table S1.
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worked extremely well for Dscam, which is a homophilic adhe-
sion molecule. The signal due to homophilic binding of the
7.13.25 isoform was 178-fold higher than that for heterophilic
binding of 7.13.25 to 7.8.25, which differs only in exon 3 (see
Wojtowicz et al., 2007 for nomenclature). We were also able to
detect concentration-dependent binding of Sas to Ptp10D using
the AlphaScreen. However, the signal-to-background ratio (Sas-
Fc::10D-AP versus Sas-Fc::69D-AP or Sas-Fc::blank) was only
6-fold (Figure S3), so this assay was inferior to the ELISA for
this ligand-receptor pair.
These results show that Sas and Ptp10D selectively interact
with each other, but do not define whether their in vivo interac-
tions are likely to be in cis (between proteins on the same cell sur-
face), in trans (between proteins on different cell surfaces), or
both. We used a cell aggregation assay to evaluate whether
Ptp10D and Sas can interact in trans. This was done by makingstable Schneider 2 (S2) cell lines expressing full-length Ptp10D
and a Sas-mCD8-GFP fusion protein. Ptp10D-expressing cells
formed small clusters (Figure 3C), consistent with the observa-
tion that 10D-AP binds to ectopically expressed Ptp10D in
embryos (Figure S1). Sas-expressing cells did not aggregate
(Figure 3D). When the cell lines were mixed, we observed
Ptp10D-expressing cell clusters that were associated with one
to several Sas-expressing cells (Figure 3E). These cells some-
times formed straight interfaces with Ptp10D cells that are sug-
gestive of adhesive interactions (Figure S3). Large cell clusters
were seldom observed, suggesting that these interactions are
weak or limited by unknown factors.
Sas and Ptp10D Are Both Expressed on CNS Axons
and Tracheal Cells
Within the CNS, Ptp10D is expressed only on axons (Sun et al.,
2000; Tian et al., 1991; Yang et al., 1991) (Figure 4A). It is alsoNeuron 78, 813–826, June 5, 2013 ª2013 Elsevier Inc. 817
Figure 4. Expression Patterns of Ptp10D and Sas at Late Stage 16
Embryos were double-stained with anti-Ptp10D mAb and rabbit anti-Sas, and
visualized by immunofluorescence.
(A) Ptp10D. Note that CNS axons are brightly stained, and cell outlines are
almost invisible. Scale bar represents 10 mm.
(B) Sas. The intersegmental (arrowhead) and segmental (double arrowhead)
nerve roots are brightly stained. Two longitudinal bundles express Sas at
higher levels within each longitudinal tract (arrows). Cell outlines are clearly
visible (asterisk).
(C) Ptp10D. The apical surfaces of tracheal branches are brightly labeled.
Arrowheads in (C) and (D) indicate the dorsal trunk. Scale bar represents
10 mm.
(D) Sas. The tracheal pattern of Sas expression is essentially identical to that of
Ptp10D.
See also Figure S4 and Table S1.
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Interactions of Ptp10D with a Cell Surface Ligandexpressed on the apical surfaces of tracheal cells (Jeon and
Zinn, 2009) (Figure 4C).
Antibody against Sas has been widely used as a selective
marker for apical cell surfaces (Schonbaum et al., 1992; Wodarz
et al., 1995). Sas is probably expressed at some level on the api-
cal surfaces of all cells of epithelial origin, including neurons and
glia. Most or all cell bodies and axons in the VNC appear to stain
with anti-Sas. Sas is expressed at higher levels on some axons
than on others, in particular on the intersegmental and segmental
nerve roots and on two longitudinal bundles on each side of the
CNS (Figure 4B). Figure S4 demonstrates that ensheathing cells
on the dorsal surface of theCNS express Sas. These are the peri-
neurial, subperineurial, interface, and channel glia (Ito et al.,
1995). In the tracheal system, the patterns of staining with
anti-Ptp10D and anti-Sas are essentially identical (Figures 4C
and 4D) (Jeon and Zinn, 2009).
Sas Is Involved in Formation of Longitudinal Axon Tracts
Although lethal ethyl methane sulfonate (EMS) mutations in sas
were isolated many years ago, little is known about the functions
of the sas gene. sas mutants do not exhibit embryonic lethality,818 Neuron 78, 813–826, June 5, 2013 ª2013 Elsevier Inc.but their postembryonic growth is stunted and they usually die
as second instar larvae (hence the name). Third instar escapers
have convoluted tracheae (Schonbaum et al., 1992), but wewere
unable to find any tracheal defects in embryos.
To evaluate whether sas mutants have CNS phenotypes, we
examined embryos homozygous for a strong EMS mutation,
sas15, or transheterozygotes bearing this mutation over Df(3R)
ED5221, which removes the entire sas gene. We sequenced
the sas gene on the sas15 chromosome, and found that sas15
introduces a stop codon after aa 642, which is N-terminal to all
conserved Sas domains. These data indicate that sas15 is likely
to be a null mutation.
To visualize CNS axons, we used mAbs BP102 and 1D4.
BP102 labels most or all CNS axons, producing a ladder-like
pattern, with two commissural tracts in each segment and two
longitudinal tracts extending the length of the embryo (Seeger
et al., 1993) (Figures 5B, 5D, and 5F). 1D4 recognizes the trans-
membrane form of FasII (Vactor et al., 1993), and stains pioneer
axons at stage 14 (Figure 5A). By late stage 16, 1D4 staining
within the CNS is restricted to three distinct longitudinal axon
bundles on each side of the VNC, and no staining is seen
on commissural axon bundles that cross the CNS midline
(Figure 5E).
sas15/Df transheterozygotes appear normal at stage 14 (Fig-
ures 5G and 5H), but display weak longitudinal axon defects at
stage 16. The outer 1D4 axon bundle is interrupted and the other
bundles appear slightly irregular (Figures 5I and 5K). Complete
breaks of a longitudinal tract are rare, but do occasionally occur.
1D4 axons ectopically cross the midline in 15% of segments.
Irregularities in the BP102 axon ladder are observed in at least
one segment of most embryos (Figures 5J and 5L). sas15 homo-
zygotes have identical phenotypes, consistent with sas15 being a
null mutation (data not shown).
Ptp10D and Sas Regulate Axon Guidance across
the Midline
To examine whether Sas is required for Ptp10D signaling using
LOF genetics requires examination of double mutant pheno-
types, because Ptp10D single null mutant embryos have no
known phenotypes. Most relevant to this study, Ptp10D
Ptp69D double null mutants have strong CNS phenotypes in
which 1D4-positive longitudinal axons that would normally
remain on one side instead cross the midline (Sun et al., 2000).
At late stage 16, most segments have a thick 1D4-positive
commissural tract with several distinct bundles, oriented
perpendicular to the longitudinal tracts. The inner longitudinal
1D4 bundle is present, but the outer two bundles are missing
or fused with the inner bundle (compare Figure 6C to 6A).
BP102 staining shows that the anterior and posterior commis-
sures are fused into a single commissural tract (compare Fig-
ure 6H to 6F). The Ptp10D Ptp69D double mutation affects a
unique subset of axons, and is quite different from other pheno-
types in which 1D4 axons cross the midline. For example, in
roundabout (robo) mutants, pioneer axons that normally extend
in the inner 1D4 bundle instead follow curving pathways across
the midline, creating distinctive circular patterns. The outer two
1D4 bundles are still present, although they are often interrupted
(Seeger et al., 1993).
Figure 5. sas LOF CNS Phenotypes
(A–L) Embryos were stained with mAb 1D4 or mAb BP102, and HRP immunohistochemistry was used for detection. Each panel shows three segments of the
VNC, which was dissected out of the embryos. The stages (14, early 16, late 16) are indicated above the panels.
(A and B) wild-type (WT; yw) stage 14 1D4 and BP102 patterns. Scale bar represents 10 mm.
(C and D) WT early stage 16 1D4 and BP102 patterns.
(E) In late stage 16 WT embryos, 1D4 labels three longitudinal bundles on each side of the CNS, and does not stain commissural axons.
(F) In late stage 16 WT embryos, a regular BP102 ladder is observed.
(G and H) sas15/Df transheterozygotes are indistinguishable from at stage 14 using either marker.
(I and J) Slight irregularities in the 1D4 and BP102 patterns are observed at early stage 16 in sas15/Df.
(K) In sas15/Df at late stage 16, the outer 1D4 bundle is interrupted (arrowhead), and there are occasional axon bundles crossing the midline (arrow).
(L) In sas15/Df at late stage 16, the BP102 ladder is slightly irregular and narrowed. One segment has an abnormal anterior commissure (bracket).
See also Table S1.
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Interactions of Ptp10D with a Cell Surface LigandThe existence of the distinctive Ptp10D Ptp69D double
mutant phenotype allows us to ask whether Sas is important
for Ptp10D signaling, by determining if loss of Sas together
with Ptp69D produces the same phenotypes as loss of
Ptp10D together with Ptp69D. Ptp10D and Ptp69D single
mutants have almost no midline crossing defects (0% in
Ptp10D, 1.4% in Ptp69D) (Sun et al., 2000). sas15/Df transheter-
ozygotes and sas15 homozygotes have 1D4-positive axon bun-
dles that cross the midline in 11%–15% of segments, and this
penetrance is increased to 22%–27% in Ptp10D sas double
mutants (Figures 6B and 6K). However, in sas Ptp69D double
mutants, 63%–74% of segments have 1D4 bundles that cross
the midline (Figures 6D and 6K). This phenotype is almost as
strong as that of Ptp10D Ptp69D double mutants, in which
1D4 bundles cross the midline in 76% of segments (Figures
6C and 6K).
The sas Ptp69D 1D4 phenotype (Figure 6D) has many of the
distinctive features of thePtp10D Ptp69D phenotype (Figure 6C).
Multiple axon bundles cross the midline in each segment, and
these are perpendicular to the longitudinal tracts, not curving
as in robo mutants. The inner longitudinal 1D4 bundle is intact,
but one or both of the outer longitudinal bundles are missing.Ptp10D Ptp69D and sas Ptp69D embryos display similar fused
commissure phenotypes, as revealed byBP102 staining (Figures
6H and 6I).
These results show that Sas is necessary for Ptp10D’s func-
tions in preventing longitudinal axons from crossing the midline.
However, the sas Ptp69D and Ptp10D Ptp69D 1D4 phenotypes
are somewhat different. Fewer 1D4-positive bundles cross the
midline in each segment in sas Ptp69D than in Ptp10D Ptp69D,
and there are more distinct bundles remaining in the longitudinal
tracts (compare Figure 6C to 6D). There are also complete
breaks in the 1D4-positive longitudinal tracts in sas Ptp69D (Fig-
ure 6D), which are not observed in Ptp10D Ptp69D.
We further analyzed these phenotypes by staining with other
markers for specific neurons and axons. Apterous (Ap)-GAL4 is
expressed in a small number of neurons whose axons extend
within a single longitudinal bundle (Garbe et al., 2007; Lundgren
et al., 1995). Surprisingly, in both Ptp10D Ptp69D and sas
Ptp69D these neurons do not extend axons at all, or have short
processes that project in the wrong direction (Figure S5). Anti-
Connectin stains two longitudinal bundles that are distinct from
the 1D4-positive bundles. Ptp10D Ptp69D and sas Ptp69D
display similar phenotypes in which the outer Connectin bundleNeuron 78, 813–826, June 5, 2013 ª2013 Elsevier Inc. 819
Figure 6. Ptp10D and Sas Work Together in Neurons to Regulate Axon Guidance across the Midline
(A–K) Late stage 16 embryos were stained with 1D4 and BP102 as described in Figure 5.
(A) WT 1D4 pattern. Scale bar represents 10 mm.
(B) Ptp10D, sas. The 1D4 pattern is like that of sas (Figure 5) with occasional axon bundles crossing the midline (arrow) and interruptions in the outer 1D4 bundle
(arrowhead). Mutant genotypes are Ptp10D1, sas15/Df(3R)ED5221.
(legend continued on next page)
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Interactions of Ptp10D with a Cell Surface Ligandis missing and there are occasional breaks in the inner bundle
(Figure S5).
To evaluate whether Sas is likely to act together with Ptp10D in
1D4-positive axons to prevent them from crossing the midline,
we expressed the Sas cDNA construct from the FasII-GAL4Mz507
driver in the sas Ptp69D double mutant background, in order to
restore Sas selectively to the same subset of CNS neurons
whose phenotype is scored through analysis of the 1D4 staining
pattern. We observed that Sas expression in FasII-positive neu-
rons almost completely rescued the sas Ptp69D CNS pheno-
types (Figures 6E, 6J, and 6K).
To test whether Sas must be expressed in FasII neurons in
order to signal to Ptp10D, we then overexpressed Sas in glia
using the Gcm-GAL4 driver in the sas Ptp69D double mutant
background. This also rescued the phenotype (Figure S5). These
data, however, do not necessarily indicate that phenotypic
rescue is the result of interactions between neuronal Ptp10D
and Sas on glial cell surfaces. When Sas is expressed in small
clusters of cells (e.g., Apterous neurons), anti-Sas antibody
staining spreads out from the cell bodies in a pattern suggesting
that nonmembrane-bound Sas proteins are deposited in the
extracellular matrix (ECM) (Figure S5). ECM-bound (‘‘soluble’’)
Sas may be able to interact with Ptp10D in the same manner
whether it is expressed on neurons or in glia.
Communication between Glia and Neurons via
Interactions between Sas and Ptp10D
We further characterized genetic interactions between sas
and Ptp10D by examining their epistatic relationships, asking
whether sas gain-of-function (GOF) phenotypes are modified
by LOFmutations in Ptp10D (Ptp10D has no known GOF pheno-
types). We overexpressed Sas cDNA in wild-type and Ptp10D
mutant backgrounds, using three drivers: the strong pan-
neuronal driver Elav-GAL4, the midline glial driver Sim-GAL4,
and Repo-GAL4, which drives expression in all glia except
midline and perineurial glia. In a wild-type background, all three
driver crosses produced weak phenotypes in which the CNS
axon ladder had a normal morphology, but axons in the inner
1D4 longitudinal bundle occasionally crossed the midline (Fig-
ures 7C and S6). In Elav > Sas embryos, 14% of segments(C) Ptp10D, Ptp69D. Thick axon bundles cross the midline in each segment (bra
Ptp10D1, Ptp69D1/Df(3L)8ex25.
(D) sas, Ptp69D. Two bundles cross the midline in each segment (bracket), an
genotypes are sas15/sas15, Ptp69D1/Df(3L)8ex25.
(E) sas, Ptp69D, FasII > Sas. The 1D4 pattern is almost like WT. Mutant g
UAS-Sas cDNA.
(F) WT BP102 pattern.
(G) The Ptp10D, sas BP102 ladder has an abnormal anterior commissure (arrow
(H) In Ptp10D, Ptp69D, the commissures are completely fused in all three seg
genotypes are Ptp10D1, Ptp69D1/Df(3L)8ex25.
(I) In sas, Ptp69D, commissural organization is disrupted (bracket), and longitudin
Ptp69D1/Df(3L)8ex25.
(J) The sas, Ptp69D, FasII > Sas BP102 pattern is almost like WT. Mutant
UAS-Sas cDNA.
(K) Bar graph quantitating the percent of segments exhibiting ectopic midline cro
black bars, sas15/Df genotypes. n, number of segments scored (n = 162 for WT [yw
sas; 522 for Ptp10D, sas/Df; 225 for Ptp10D Ptp69D; 324 for sas, Ptp69D; 685
FasII > Sas). p < 0.00001 for the differences in penetrance between sas/Df and s
See also Figure S5 and Table S1.had 1D4-positive axons crossing themidline, and this phenotype
was not enhanced or suppressed when Ptp10D was genetically
removed (Figure S6).
The Sim-GAL4 and Repo-GAL4 crosses, in which Sas is over-
expressed in cells that do not express endogenous Ptp10D,
behaved differently. Approximately 5% of segments had 1D4-
positive axons crossing the midline with each driver (Figures
7C, 7E, and S6). When Ptp10D was genetically removed, these
phenotypes were enhanced, suggesting that signaling by over-
expressed glial Sas is negatively regulated by neuronal
Ptp10D. For Sim > Sas, 11% of segments displayed ectopic
midline crossing in thePtp10D background, but the overall struc-
ture of the CNS was unchanged (Figure S6). For Repo > Sas,
however, loss of Ptp10D produced a phenotype in which the
entire pattern of 1D4-positive axons was dramatically altered,
and >50% of segments had ectopic midline crossing (Figures
7D and 7E). We asked whether negative regulation of glial Sas
signaling by Ptp10D requires that Ptp10D be expressed on neu-
rons by driving both Sas and Ptp10D in glia in a Ptp10D mutant
background. Glial coexpression of Sas and Ptp10D was able to
rescue the midline crossing phenotype (Figure S6).
Although the Ptp10D, Repo > Sas phenotype, like the Ptp10D
Ptp69D and sas Ptp69D double mutant phenotypes, is quantita-
tively analyzed by scoring ectopic midline crossing, it is qualita-
tively a different phenotype. In Ptp10D, Repo > Sas embryos, the
inner 1D4 bundle crosses the midline, but the outer bundles,
which cross in Ptp10D Ptp69D, usually do not (Figure 7D;
compare to Figures 6C and 6D). The phenotype is of variable
strength, and has similarities to those of mutants with defects
in Slit-Robo pathway components (Bashaw et al., 2000; Seeger
et al., 1993).
The axon guidance phenotype seen in Ptp10D, Repo > Sas
embryos is an indirect consequence of overexpression of Sas
in glia. To examine whether the glia themselves are visibly
altered by Sas overexpression, we crossed in a UAS-nuclear
dsRed construct and visualized Repo-GAL4-expressing nuclei
using anti-dsRed antibodies. In Figures 7F–7I, we show the
focal plane containing the nuclei of the interface glia, which lie
just dorsal to the axon ladder and are required for normal
axon guidance. Nuclei of nerve root glia and some of thecket), and there is only one distinct longitudinal bundle. Mutant genotypes are
d segments of the outer longitudinal tract are missing (arrowhead). Mutant
enotypes are sas15/Df(3R)ED5221, Ptp69D1/Df(3L)8ex25, FasII-GAL4Mz507,
head). Mutant genotypes are Ptp10D1, sas15/Df(3R)ED5221.
ments (bracket), and the longitudinal tracts are thinned (arrowhead). Mutant
al tracts are thinned (arrowhead). Mutant genotypes are sas15/Df(3R)ED5221,
genotypes are sas15/Df(3R)ED5221, Ptp69D1/Df(3L)8ex25, FasII-GAL4Mz507,
ssing of 1D4 axons. Brown bar, Ptp10D Ptp69D; gray bars, sas15 genotypes;
]; 128 for Ptp10D; 738 for Ptp69D; 864 for sas; 585 for sas/Df; 702 for Ptp10D,
for sas/Df, Ptp69D, 567 for sas, Ptp69D, FasII > Sas; 284 for sas/Df, Ptp69D,
as/Df Ptp69D, and between sas/Df Ptp69D and sas/Df Ptp69D, FasII > Sas.
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Figure 7. Interactions between Glial Sas and Axonal Ptp10D Affect Glial Organization and Axon Guidance
(A–I) Late stage 16 embryos were stained with 1D4 as described in Figure 5.
(A–C) A normal 1D4 pattern is observed, although the 1D4 bundles are slightly wavy in Repo > Sas (C), and one segment has an axon bundle crossing the midline
(arrow). Scale bar represents 10 mm.
(D) In Ptp10D1, Repo > Sas, a strong axon guidance phenotype is observed. The inner 1D4 bundle crosses the midline in all three segments (arrow), and the
longitudinal bundles are partially fused and disrupted (arrowhead).
(E) Bar graph quantitating the percentage of segments exhibiting ectopicmidline crossing of 1D4 axons. n = 162 forWT; 128 for Ptp10D; 414 for Repo > Sas; 424
for Ptp10D, Repo > Sas. p < 0.00001 for the difference in penetrance between Repo > Sas and Ptp10D, Repo > Sas.
(F–H) The lower row of panels shows glial nuclei, visualized with anti-dsRed. Repo-GAL4 was used to drive RedStinger (a nuclear version of dsRed) in the
indicated genotypes. The focal plane is at the level of the interface glia. Note the organized glial lattice in (F)–(H), with a double vertical row of nuclei along each
longitudinal tract and a band of nuclei crossing the midline in each segment. The vertical rows are slightly irregular in (H).
(I) In Ptp10D1, Repo > Sas, the glial lattice is disrupted. The vertical rows have become aggregations of varying width, and there is no regular pattern of glial nuclei
near the midline.
See also Figure S6 and Table S1.
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Interactions of Ptp10D with a Cell Surface Ligandchannel and subperineurial glia are also visible within this focal
plane (Ito et al., 1995).
CNS glia migrate extensively between stages 13 and 16, so
that glial nuclear patterns undergo rapid changes (reviewed by
Hidalgo and Griffiths, 2004). At late stage 16, glial nuclei in the
focal plane of Figure 7F are organized in a semiregular lattice
in wild-type embryos, with two rows of nuclei extending along
each longitudinal tract and a segmentally repeated pattern of
nuclei closer to themidline. The analysis of this pattern is compli-
cated by the large numbers of glia, their distribution throughmul-
tiple focal planes, and the dynamic nature of the pattern. Even in
wild-type, there is substantial variation between glial lattices in
different embryos that appear to be at the same stage of devel-
opment. This is in contrast to the essentially invariant nature of
the pattern of 1D4-positive axons in late stage 16 wild-type
embryos (compare Figures 5E, 6A, and 7A).
Despite these caveats, it is clear that wild-type, Ptp10D, and
Repo > Sas embryos all have organized glial lattices with a
similar overall appearance, although the Repo > Sas lattice is
somewhat irregular (Figures 7F–7H). By contrast, in Ptp10D,
Repo > Sas embryos the pattern of glial nuclei is quite disorga-
nized (Figure 7I). The double row of nuclei along each longitudi-
nal tract is replaced by aggregations of varying width, and there
is no segmentally repeated pattern of nuclei near the midline.
These results show that when Sas is overexpressed in glia in
embryos lacking the neuron-specific Ptp10D protein, it gener-
ates a phenotype characterized by glial disorganization and
altered CNS axon guidance. Interactions between neuronal
Ptp10D and glial Sas appear to hold Sas activity in check
when it is overexpressed, thereby preserving the relatively
normal glial and axonal patterns seen in Repo > Sas embryos.
DISCUSSION
We devised a screen for orphan receptor ligands in which CSS
proteins are ectopically expressed in embryos and ligand candi-
dates are identified by the presence of ectopic staining with
receptor-AP fusion proteins. We performed a screen of GAL4-
dependent insertion lines for 311 CSS protein genes (Table S1)
with the XC domain of the Ptp10D RPTP, and identified a gene
encoding the cell-surface protein Sas (Schonbaum et al., 1992)
(Figures 1 and 2). We used a modified ELISA assay to
show that Sas and Ptp10D selectively bind to each other in
the absence of other cofactors, and demonstrated that Sas
and Ptp10D-expressing cells can aggregate with each other
(Figure 3).
Ptp10D is selectively expressed on CNS axons (Sun et al.,
2000; Tian et al., 1991; Yang et al., 1991) (Figure 4A), and func-
tions redundantly with Ptp69D to prevent a specific subset of
longitudinal axons from crossing the midline (Sun et al., 2000).
Ptp10D Ptp69D and sas Ptp69D double mutants both have
strong ectopic midline crossing phenotypes, suggesting that
Sas is required for Ptp10D signaling in the context of longitudinal
axon guidance (Figures 6 and 8A).
Sas appears to be expressed on all cells in the CNS, including
glia (Figures 4 and S4). We conducted genetic epistasis experi-
ments by overexpressing Sas in glia and asking whether loss
of the neuron-specific Ptp10D modifies the resulting phenotype.The results suggest that overexpressed Sas can produce a
signal that alters glia and affects their communication with neu-
rons (Figure 7). Interactions between Ptp10D and Sas suppress
the production of this signal (Figure 8B).
Ptp10D/Sas Signaling in Neurons Controls Guidance of
Longitudinal Axons
RPTP signaling controls the decisions by axonal growth cones to
choose longitudinal versus commissural pathways, because in a
quadruple Rptp mutant (Ptp10D Lar Ptp69D Ptp99A), all 1D4
(FasII)-positive longitudinal axons are diverted into the commis-
sures and the longitudinal bundles are absent. Ptp10D and
Ptp69D are key to these guidance decisions, because triple
Rptp mutants in which either Ptp10D or Ptp69D is wild-type
have a relatively normal 1D4 pattern, but any mutant combina-
tion that includes both Ptp10D and Ptp69D mutations has thick
1D4-positive commissures (Sun et al., 2001). This suggests
that Ptp10D and Ptp69D share some critical substrate(s) or inter-
acting protein(s) that controls these decisions.
sas Ptp69D double mutants also have strong ectopic midline
crossing phenotypes that are rescued by selective expression
of Sas in FasII neurons (Figure 6). The simplest model to explain
these findings is that Ptp10D forms a complex with Sas in FasII-
expressing longitudinal tract neurons in order to activate the
downstream signaling pathway(s) that it shareswith Ptp69D (Fig-
ure 8A). However, the axons of FasII neurons bundle together, so
Sas on one axon could contact Ptp10D on another axon. The sas
Ptp69D phenotype can also be rescued by expression of Sas in
glia, and Sas protein(s) appear to be deposited in the ECM (Fig-
ure S5). Thus, signaling interactions relevant to midline crossing
might also be mediated by binding of soluble Sas to Ptp10D on
axons.
Signaling by Overexpressed Glial Sas Is Negatively
Regulated by Interactions with Neuronal Ptp10D
Longitudinal axon guidance and interface glial development are
intertwined processes (for review, see Hidalgo and Griffiths,
2004). Perturbation of interface glia can cause longitudinal axons
to cross themidline (Kinrade and Hidalgo, 2004). Conversely, the
fates of longitudinal glia, which are a subset of the interface glia
(Ito et al., 1995), are controlled by signals from neurons (Griffiths
and Hidalgo, 2004; Thomas and van Meyel, 2007).
The analysis of glial-neuronal interactions provides an excel-
lent system in which to examine whether signaling through Sas
can be regulated by interaction with Ptp10D. Ptp10D is only on
axons, whereas Sas is expressed on glia (Figures 4 and S4).
Driving Sas overexpression in glia with Repo-GAL4 produces
only subtle phenotypes. However, genetic removal of Ptp10D
from Repo > Sas embryos generates strong ectopic midline
crossing phenotypes. These phenotypes are accompanied by
disorganization of interface glia (Figure 7). Glial mispositioning
might be sufficient to affect axon guidance. However, given the
severity of the axonal phenotype, we think it more likely that
the disruption of the glial lattice is reflective of changes in gene
expression that cause the glia to send abnormal axon guidance
signals to the neurons (Figure 8B).
The 37 aa Sas cytoplasmic domain interacts with Numb in the
yeast two-hybrid assay (Chien et al., 1998). Numb is an inhibitorNeuron 78, 813–826, June 5, 2013 ª2013 Elsevier Inc. 823
Figure 8. Models for Signaling by Ptp10D
and Sas
(A) Models for signaling in neurons in wild-type.
The sas Ptp69D phenotype is rescued by Sas
expression in longitudinal tract neurons, suggest-
ing that either: (1) Sas interacts with Ptp10D in the
same cell, or (2) ECM-bound or transmembrane
Sas on other longitudinal axons interacts with
Ptp10D. Ptp10D/Sas and Ptp69D may both affect
the activity of a common downstream signaling
protein(s) that helps prevent longitudinal axons
from crossing the midline. Ptp69D is cleaved as
indicated. Triangles, VWC domains; blue circles,
FN3 repeats (Ptp10D actually has 12); rectangles,
Ig domains; red circles, PTP domains; double
green lines, cell membranes.
(B) Model for signaling between glia and neurons
in embryos overexpressing Sas in glia. Overex-
pressed Sas produces a signal in glia (top) that
alters their presentation of axon guidance cues to
neurons (bottom). Generation of the signal is suppressed (t symbol) by interactions between neuronal Ptp10D and glial Sas. Triangles, VWC domains; blue
circles, FN3 repeats (Ptp10D actually has 12); rectangles, Ig domains; red circles, PTP domains; double green lines, cell membranes.
See also Table S1.
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signaling affect longitudinal glia (Griffiths et al., 2007; Griffiths
and Hidalgo, 2004; Kato et al., 2011; Thomas and van Meyel,
2007). We suggest that when Sas is overexpressed in glia and
is not restrained by Ptp10D binding, it might sequester Numb,
thereby increasing Notch signaling.
Comparison to Other Ligand-Receptor Systems
Involved in Axon Guidance
Binding of Sas to Ptp10D on longitudinal axons facilitates
Ptp10D’s functions in regulation of CNS axon guidance. In
glia, overexpressed Sas produces a signal that is suppressed
by interactions with neuronal Ptp10D (Figure 8). Other receptors
involved in axon guidance exhibit interactions with ligands that
produce different signaling outcomes depending on whether
the ligands and receptors are expressed on the same or on
different cells. In retinal ganglion cells and spinal motor neu-
rons, Eph RTKs interact with Ephrin ligands both on other cells
(in trans) and on the same cells (in cis), and cis interactions
attenuate the responses of the RTKs to ligand presented in
trans (Carvalho et al., 2006; for review, see Dudanova and Klein,
2011).
Like Sas, Ephrins and type III neuregulin 1, a ligand for ErbB
RTKs, also generate ‘‘reverse’’ signals in the cells that express
them that are important for axon pathfinding (Hancock et al.,
2011). However, Ephrin and neuregulin signals are produced
upon engagement of the ligands with their receptors, not
blocked by receptor engagement as in the case of Sas and
Ptp10D.
EXPERIMENTAL PROCEDURES
Genetics
FasII-GAL4Mz507 was from Hermann Aberle. Ptp10D is on the X, and is exam-
ined as a hemizygote. Ptp10D1, which is a P element excision mutation that
deletes N-terminal coding sequence, eliminates all detectable protein expres-
sion (Jeon and Zinn, 2009; Sun et al., 2000). For Ptp69D, transheterozygotes824 Neuron 78, 813–826, June 5, 2013 ª2013 Elsevier Inc.between 50 (Ptp69D1) and 30 (Df(3L)8ex25) excision mutations, both of which
remove coding sequence, are used in order to generate a null phenotype
affecting only Ptp69D (Desai et al., 1996). Crosses and embryo collections
were performed at room temperature. For the screen, embryos were shifted
to 29C for 60 min prior to dissection. For Sas overexpression experiments,
embryos were shifted to 29C for 90 min prior to fixation and staining. To
express Sas and Ptp10D together on glia in a Ptp10D background (Figure S6),
we used the Ptp10DEP1172 allele, which reduces Ptp10D expression and pro-
duces a phenotype when combined with Ptp69D (Sun et al., 2000), but also
confers GAL4-dependent Ptp10D expression.
Immunohistochemistry
Procedures for live dissection and RPTP-AP staining were described previ-
ously (Fox and Zinn, 2005; Lee et al., 2009). For whole-mount antibody stain-
ing of embryo collections, we modified procedures described by Patel (1994).
The following antibodies were used: mAb 1D4 (Vactor et al., 1993; used
at 1:3), mAb BP102 (Seeger et al., 1993; used at 1:20), mAb 8B2 against
Ptp10D (Kurusu and Zinn, 2008; used at 1:5); rabbit-anti-Sas (Schonbaum
et al., 1992; used at 1:2,000, gift of D. Cavener, Penn State University); rabbit
anti-AP (Serotec, used at 1:600); rabbit-anti-RFP (dsRed) (Rockland, used at
1:1,000); rabbit anti-GFP (Invitrogen, used at 1:1,000); Rhodamine-conju-
gated phalloidin (Invitrogen, used at 1:2,000); AlexaFluor 488 anti-mouse
and AlexaFluor 568 anti-rabbit (Invitrogen, used at 1:1,000); and HRP-conju-
gated goat-anti-mouse and goat anti-rabbit (Jackson ImmunoResearch, used
at 1:150).
Molecular Biology
The Sas cDNA construct wasmade using a full-length cDNA clone for the 1693
aa protein. This was inserted into pUAST-attB, and site-specific X and second
chromosome transgenics were made by Rainbow Genetics. Expression of
RPTP-AP proteins using baculovirus was described by Fox and Zinn (2005).
Sas-Fc was made by inserting the entire XC domain sequence of Sas into
an S2 expression vector containing the human Fc sequence with a His tag
(Wojtowicz et al., 2007). Then, the entire Sas-Fc coding region, minus the
signal sequence, was amplified by PCR from this plasmid and inserted into
a baculovirus vector, pAcGP67A. Sas-Fc was purified from supernatants of
cells infected with the virus derived from this vector, using Ni-NTA agarose.
We PCR-amplified exons of the sas15 gene from sas15 homozygote larvae
and sequenced multiple clones from multiple amplifications to ensure that
observed changes were due to mutation and not to PCR errors. We observed
changes from wild-type as follows: exon 2, position 3,530, noncoding; exon 2,
Neuron
Interactions of Ptp10D with a Cell Surface Ligandposition 3,590, noncoding (5 bp deletion); exon 2, position 3,784, missense;
exon 6, position 17,890, nonsense (stop codon mutation at aa 642); exon 6,
position 18,024, missense; exon 9, position 20,000, missense.
ELISA Method
Each well of Nunc Immunosorb 96-well plates was incubated overnight at 4C
with 50 ml (3 mg/ml antibody) of unpurified ascites fluid containing the IgG2A
anti-AP mAb 8B6 (Sigma) in 13 PBS, pH 7.4. Wells were washed five times
for 1–3 min at room temperature with 150 ml 13 PBS, pH 7.4 + 0.05%
Tween-20 (PBST). Wells were incubated for 1–2 hr at room temperature with
150 ml 1% casein in 13 PBS, pH 7.4, on a rocking platform. The 1% casein
blockwas removed. This was followed by the addition of 20 ml Fc fusion protein
(Sas-Fc [5 ng/ml], Unc5-Fc [5 ng/ml] or FasII-Fc [5 ng/ml]) and 20 ml AP fusion
protein (10D-AP [8.5 ng/ml], Lar-AP [8.5 ng/ml], 69D-AP [8.5ng/ml], or blank cul-
ture medium), for a total volume of 40 ml. The AP fusion protein dilutions also
contained HRP-conjugated mouse anti-human IgG1 (2 mg/ml; Serotec). Plates
were covered and incubated overnight at room temperature protected from
light. The next day, wells were washed five times for 1–3 min at room temper-
ature with 150 ml PBST. 1-Step Ultra TMB-ELISA HRP substrate (100 ml; Pierce
catalog 34028) equilibrated to room temperature was added and plates were
incubated for 1 hr at room temperature. Absorbance at both 370 nm and
652 nm wavelengths was measured using an ND-1000 spectrophotometer.
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